Literature DB >> 30801866

The impact of changing practice on improved outcomes of paediatric renal transplantation in the United Kingdom: a 25 years review.

Lisa Mumford1, Heather Maxwell2, Niaz Ahmad3, Stephen D Marks4, Jane Tizard5.   

Abstract

This review reports the outcomes of paediatric renal transplantation in the United Kingdom over the last 25 years. UK Transplant Registry data on 3236 paediatric renal transplants performed between 1 January 1992 and 31 December 2016 were analysed. Significant improvements in human leucocyte antigen (HLA) matching have been achieved; 84% of recipients received 000 or favourable (0 DR and 0 or 1 B) mismatched kidneys in 2016 compared with 27% in 1992. The median waiting time has increased from 126 days in 1999 to 351 days in 2016. Tacrolimus replaced ciclosporin in most immunosuppressive regimens after 2002. Renal transplant outcome has improved significantly, mainly because of a reduction in early graft loss. One-year donation after brain death renal allograft survival for those transplanted from 2012 to 2016 was 98%, compared with 72% for those transplanted from 1987 to 1991. Renal allograft survival for first kidney only transplants at 1, 5, 10, 20 and 25 years were 89%, 79%, 65%, 42% and 33% respectively. Superior survival with living donor was maintained throughout the study period with 25-year graft survival at 33% compared with 31% from deceased donor (P < 0.0001). Changes in immunosuppression regimens, improvements in HLA matching and a reduction of cold ischaemia time may in part explain the improvements in graft survival.
© 2019 Steunstichting ESOT.

Entities:  

Keywords:  human leucocyte antigen; immunosuppression; kidney; paediatric transplantation; renal; survival

Mesh:

Substances:

Year:  2019        PMID: 30801866     DOI: 10.1111/tri.13418

Source DB:  PubMed          Journal:  Transpl Int        ISSN: 0934-0874            Impact factor:   3.782


  6 in total

1.  Utilisation of kidneys from deceased donors at increased risk of infectious disease transmission: a step in the right direction.

Authors:  Chris J Callaghan; Stephen D Marks
Journal:  Pediatr Nephrol       Date:  2019-10-30       Impact factor: 3.714

2.  CMV, EBV, JCV and BKV infection and outcome following kidney transplantation in children initiated on a corticosteroid-minimisation immunosuppressive regimen.

Authors:  James McCaffrey; Vijesh J Bhute; Mohan Shenoy
Journal:  Pediatr Nephrol       Date:  2021-04-06       Impact factor: 3.714

Review 3.  Long-Term Care of the Pediatric Kidney Transplant Recipient.

Authors:  Hilda E Fernandez; Bethany J Foster
Journal:  Clin J Am Soc Nephrol       Date:  2021-05-12       Impact factor: 8.237

4.  Improve in-depth immunological risk assessment to optimize genetic-compatibility and clinical outcomes in child and adolescent recipients of parental donor kidney transplants: protocol for the INCEPTION study.

Authors:  Wai H Lim; Brigitte Adams; Stephen Alexander; Antonia H M Bouts; Frans Claas; Michael Collins; Elisabeth Cornelissen; Heather Dunckley; Huib de Jong; Lloyd D'Orsogna; Anna Francis; Sebastiaan Heidt; Jean Herman; Rhonda Holdsworth; Joshua Kausman; Rabia Khalid; Jon Jin Kim; Siah Kim; Noël Knops; Vasilis Kosmoliaptsis; Cynthia Kramer; Dirk Kuypers; Nicholas Larkins; Suetonia C Palmer; Chanel Prestidge; Agnieszka Prytula; Ankit Sharma; Meena Shingde; Anne Taverniti; Armando Teixeira-Pinto; Peter Trnka; Francis Willis; Daniel Wong; Germaine Wong
Journal:  BMC Nephrol       Date:  2021-12-19       Impact factor: 2.388

5.  Acute rejection and growth outcomes in paediatric kidney allograft recipients treated with a corticosteroid minimisation immunosuppressive protocol.

Authors:  James McCaffrey; Mohan Shenoy
Journal:  Pediatr Nephrol       Date:  2021-02-09       Impact factor: 3.714

Review 6.  Does HLA matching matter in the modern era of renal transplantation?

Authors:  Jon Jin Kim; Susan V Fuggle; Stephen D Marks
Journal:  Pediatr Nephrol       Date:  2019-12-09       Impact factor: 3.714

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.